Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019
OS after ASCT for DLBCL patients in Germany is higher than previously reported and may still be considered a valid option for carefully selected patients with relapsed/refractory DLBCL.
Authors
- Michael S. Papadimitrious
- Sybille Riou
- Jan‐Michel Heger (ORCID: https://orcid.org/0000-0001-9463-8504)
- Peter Borchmann (ORCID: https://orcid.org/0000-0003-3782-2158)
- Jörg Mahlich (ORCID: https://orcid.org/0000-0003-1110-2793)
- Barbara G. Werner
Institutions
- Miltenyi Biotec (Germany) (DE)
- University of Cologne (DE)
- Düsseldorf University Hospital (DE)
- DAK-Gesundheit (Germany) (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.3389/fonc.2024.1432310
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Miltenyi Biotec